Literature DB >> 21236424

Maturation and fertilization of nonhuman primate oocytes are compromised by oral administration of a cyclooxygenase-2 inhibitor.

Diane M Duffy1, Catherine A VandeVoort.   

Abstract

OBJECTIVE: To determine if oral administration of a cyclooxygenase-2 (COX2) inhibitor affects oocyte nuclear maturation and fertilization in nonhuman primates.
DESIGN: Laboratory research study.
SETTING: Medical school. ANIMAL(S): Adult female cynomolgus monkeys (Macaca fascicularis). INTERVENTION(S): Monkeys received gonadotropins to stimulate multiple follicular development. An ovulatory dose of hCG was administered either alone or with oral celecoxib, a COX2 inhibitor. Oocytes were retrieved 36 hours later and exposed to sperm in vitro. MAIN OUTCOME MEASURE(S): Oocytes were assessed for nuclear status at retrieval, resumption of meiosis in vitro, and success of in vitro fertilization. RESULT(S): Treatment with hCG alone yielded oocytes that were primarily (72.9%) at the meiosis II (MII) stage of nuclear maturation; few oocytes were obtained at the germinal vesicle and germinal vesicle breakdown stages. Treatment with hCG and celecoxib yielded fewer mature (MII) oocytes (35.6%) and more oocytes at less mature stages compared with oocytes from monkeys treated with hCG alone. The majority (68.3 ± 15.9%) of MII oocytes from monkeys treated with hCG alone fertilized in vitro, compared with only 11.0 ± 5.9% of MII oocytes from monkeys treated with hCG and celecoxib. CONCLUSION(S): Oral administration of a COX2 inhibitor reduced the rate of oocyte nuclear maturation and the success of in vitro fertilization. Drugs of this class may block multiple essential steps in female reproduction and be effective contraceptives for women.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236424      PMCID: PMC3053529          DOI: 10.1016/j.fertnstert.2010.12.048

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  40 in total

1.  The late induction of prostaglandin G/H synthase-2 in equine preovulatory follicles supports its role as a determinant of the ovulatory process.

Authors:  J Sirois; M Doré
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

Authors:  H Lim; B C Paria; S K Das; J E Dinchuk; R Langenbach; J M Trzaskos; S K Dey
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

3.  Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study.

Authors:  M S Bata; M Al-Ramahi; A S Salhab; M N Gharaibeh; Jill Schwartz
Journal:  J Clin Pharmacol       Date:  2006-08       Impact factor: 3.126

4.  Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.

Authors:  D W Thomas; R B Mannon; P J Mannon; A Latour; J A Oliver; M Hoffman; O Smithies; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

5.  The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth.

Authors:  M Nguyen; T Camenisch; J N Snouwaert; E Hicks; T M Coffman; P A Anderson; N N Malouf; B H Koller
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

6.  Adipose differentiation-related protein: a gonadotropin- and prostaglandin-regulated protein in primate periovulatory follicles.

Authors:  Carrie L Seachord; Catherine A VandeVoort; Diane M Duffy
Journal:  Biol Reprod       Date:  2005-02-02       Impact factor: 4.285

7.  Prostaglandin dehydrogenase and prostaglandin levels in periovulatory follicles: implications for control of primate ovulation by prostaglandin E2.

Authors:  Diane M Duffy; Brandy L Dozier; Carrie L Seachord
Journal:  J Clin Endocrinol Metab       Date:  2004-11-02       Impact factor: 5.958

8.  Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2).

Authors:  H Hizaki; E Segi; Y Sugimoto; M Hirose; T Saji; F Ushikubi; T Matsuoka; Y Noda; T Tanaka; N Yoshida; S Narumiya; A Ichikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

9.  Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3.

Authors:  F Ushikubi; E Segi; Y Sugimoto; T Murata; T Matsuoka; T Kobayashi; H Hizaki; K Tuboi; M Katsuyama; A Ichikawa; T Tanaka; N Yoshida; S Narumiya
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

10.  Comparative maturation of cynomolgus monkey oocytes in vivo and in vitro.

Authors:  Hang Yin; Diane M Duffy; Roger G Gosden
Journal:  Reprod Biol Endocrinol       Date:  2006-04-04       Impact factor: 5.211

View more
  4 in total

Review 1.  Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway.

Authors:  Diane M Duffy
Journal:  Hum Reprod Update       Date:  2015-05-29       Impact factor: 15.610

Review 2.  Conservative Nonhormonal Options for the Treatment of Male Infertility: Antibiotics, Anti-Inflammatory Drugs, and Antioxidants.

Authors:  Aldo E Calogero; Rosita A Condorelli; Giorgio Ivan Russo; Sandro La Vignera
Journal:  Biomed Res Int       Date:  2017-01-09       Impact factor: 3.411

3.  BOEC-Exo Addition Promotes In Vitro Maturation of Bovine Oocyte and Enhances the Developmental Competence of Early Embryos.

Authors:  Yiran Wei; Muhammad Idrees; Tabinda Sidrat; Myeondon Joo; Lianguang Xu; Jonghyeok Ko; Ilkeun Kong
Journal:  Animals (Basel)       Date:  2022-02-10       Impact factor: 2.752

Review 4.  The Biological Role of Hyaluronan-Rich Oocyte-Cumulus Extracellular Matrix in Female Reproduction.

Authors:  Eva Nagyova
Journal:  Int J Mol Sci       Date:  2018-01-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.